Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
This raises the enduring question of the relationship between physical pain, mental pain, and suicidality.As reviewed by Elman et al. (2), several lines of evidence suggest that the colloquial terms "broken heart" and "heartache" may reflect a sad existential truth: mental pain hurts so much that it may lead to suicide.Since Shakespeare's "To be, or not to be" monologue, in which Prince Hamlet contemplates suicide in order to "end the Heart-ache" (3), mental pain has been associated with suicidality in poetry and prose.Many, and perhaps most, suicidal individuals who come to the attention of mental health professionals seek death not because they want to stop living but because they want to stop suffering.In a recent systematic review, Verrocchio et al. concluded that "mental pain is a core clinical factor for understanding suicide" (4).Specifically, they found mental pain to be a stronger factor of vulnerability for suicidal ideation than depression.Mood symptoms may be experienced and described as physical pain in some cultures, and mood and somatic symptoms are often positively correlated (5).However, we agree with Verrocchio et al. that mental pain "is no less real than other types of grief" (4).In our opinion, clinicians should be open to the possibilitynot the certainty-that judicious short-term use of ultra-lowdose buprenorphine may quickly decrease severe suicidal ideation by ameliorating the experience of mental pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., Yao, W., Ma, M., Dong, C., & Hashimoto, K. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.136 · Cited by 605
Self-citationSingh, J. B., Fedgchin, M., Daly, E. J., De Boer, P., Cooper, K., Lim, P., Pinter, C., Murrough, J. W., Sanacora, G., Shelton, R. C., et al. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16010037 · Cited by 525
R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Zhang, J.-C., Li, S.-X., & Hashimoto, K. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.033 · Cited by 357
Self-citationYang, C., Han, M., Zhang, J.-C., Ren, Q., & Hashimoto, K. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.03.034 · Cited by 91
Self-citation
Cited by
Hashimoto, K. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12902 · Cited by 335
Self-citationMolecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
Wei, Y., Chang, L., & Hashimoto, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01121-1 · Cited by 248
Self-citationYang, C., Yang, J., Luo, A., & Hashimoto, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0624-1 · Cited by 190
Self-citationChang, L., Zhang, K., Pu, Y., Qu, Y., Wang, S.-M., Xiong, Z., Ren, Q., Dong, C., Fujita, Y., & Hashimoto, K. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.04.008 · Cited by 176
Self-citationAn update on ketamine and its two enantiomers as rapid-acting antidepressants
Zhang, K., & Hashimoto, K. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1554434 · Cited by 132
Self-citation
Metadata
- Authors
- Hashimoto, K.
- Venue
- American Journal of Psychiatry
- Published
- 2016-10-01
- Volume
- 173
- Issue
- 10
- Pages
- 1044-1045
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2526508623
- Cited by
- 35
- References
- 4
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Detrimental Side Effects of Repeated Ketamine Infusions in the Brain. https://app.cochat.ai/papers/10.1176/appi.ajp.2016.16040411
- The paper
- Hashimoto, K. (2016). Detrimental Side Effects of Repeated Ketamine Infusions in the Brain. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2016.16040411
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.